Screening for structural variants of four candidate genes in dogs

November 7, 2020
 |  No Comments
geno-type

CircRNA_100782 promotes roliferation and metastasis of gastric most cancers by downregulating tumor suppressor gene Rb by adsorbing miR-574-3p in a sponge kind

Objective: The purpose of this analysis is to research the expression ranges of circRNA_100782 in gastric most cancers tissues, and its carry out of regulating tumor suppressor gene Rb by absorbing miR-574-3p in a sponge kind.

 

Victims and methods: qRT-PCR was carried out to detect the expressions of circRNA_100782 at completely totally different phases all through gastric most cancers tissues. CCK-Eight assay was carried out to guage the osteoclast proliferation and differentiation. The correlation between miR-574-3p and circRNA_100782 was detected by statistical analysis. Bioinformatics and Luciferase assay have been carried out to find the interaction and binding web site of circRNA_100782 and miR-574-3p. The mice Rb 3′-UTR have been cloned into the Luciferase reporter vector and miR-574-3p binding mutants have been constructed to validate the inhibited regulation of miR-574-3p to the expression of Rb.

 

Outcomes: Throughout the current analysis, in distinction with adjoining non-cancerous common tissues, the expressions of circRNA_100782 and Rb have been every downregulated in human gastric most cancers cells. By way of qRT-PCR and CCK-Eight assay, we found that the expression of circRNA_100782 is expounded to the proliferation of gastric most cancers cells. Along with, we moreover found that circRNA_100782 regulated the migration functionality of gastric most cancers cells by transwell assay.

 

The bioinformatics prediction and luciferase assay demonstrated that circRNA_100782 can perform a molecular sponge to extra regulate the expression of Rb by sponging with miR-574-3p; moreover, circRNA_100782 can perform a ceRNA for miR-574-3p to extra regulate the expression of Rb.

 

Conclusions: On this evaluation, we discovered that circRNA_100782 was downregulated in gastric most cancers cells and is said to cell proliferation and invasion by inhibiting tumor suppressor gene Rb by interacting with miR-574-3p.

geno-type

geno-type

Olaparib
GP0126-1 1
EUR 395.5

Olaparib
GP0126-100 100
EUR 83.1

Olaparib
GP0126-100MG 100 mg
EUR 136.8

Olaparib
GP0126-1G 1 g
EUR 514.8

Olaparib
GP0126-250 250
EUR 150.4

Olaparib
GP0126-250MG 250 mg
EUR 217.2

Olaparib
T3015-10mg 10mg Ask for price
Description: Olaparib

Olaparib
T3015-1g 1g Ask for price
Description: Olaparib

Olaparib
T3015-1mg 1mg Ask for price
Description: Olaparib

Olaparib
T3015-50mg 50mg Ask for price
Description: Olaparib

Olaparib
T3015-5mg 5mg Ask for price
Description: Olaparib

Olaparib
abx282544-100g 100 µg Ask for price

Olaparib
abx282544-20g 20 µg
EUR 106.25

Olaparib
abx282544-50g 50 µg
EUR 212.5

Olaparib
MBS6104309-100mg 100mg
EUR 540

Olaparib
MBS6104309-250mg 250mg
EUR 715

Olaparib
MBS6104309-25mg 25(mg
EUR 280

Olaparib
MBS6104309-50mg 50mg
EUR 470

Olaparib
MBS6104309-5x250mg 5x250mg
EUR 3075

Olaparib
MBS3605894-100mg 100mg
EUR 240

Olaparib
MBS3605894-10mg 10mg
EUR 210

Olaparib
MBS3605894-25mg 25mg
EUR 215

Olaparib
MBS3605894-50mg 50mg
EUR 225

Olaparib
MBS3605894-5mg 5mg
EUR 200

Olaparib-d5
T12292-10mg 10mg Ask for price
Description: Olaparib-d5

Olaparib-d5
T12292-1g 1g Ask for price
Description: Olaparib-d5

Olaparib-d5
T12292-1mg 1mg Ask for price
Description: Olaparib-d5

Olaparib-d5
T12292-50mg 50mg Ask for price
Description: Olaparib-d5

Olaparib-d5
T12292-5mg 5mg Ask for price
Description: Olaparib-d5

Olaparib-d5
HY-10162S 1 mg
EUR 627.72
Description: Olaparib-d5 is a deuterium labeled Olaparib. Olaparib is a potent and oral PARP inhibitor[1].

Olaparib-d8
HY-10162S1 1 mg
EUR 919.93
Description: Olaparib-d8 is the deuterium labeled Olaparib (AZD2281). Olaparib is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator[1][2][3][4].

AZD2281 (Olaparib)
27003 250 mg
EUR 200
Description: AZD2281, also known as Olaparib, is a poly(ADP-ribose) polymerase 1 (PARP1) inhibitor and an anti-cancer drug being tested in patients with mutations in the genes BRCA1 or BRCA2.

Olaparib (AZD2281)
E1KS1060 10mg
EUR 303

Olaparib (AZD2281)
MBS8506385-10mg 10mg
EUR 380

Olaparib (AZD2281)
MBS8506385-5x10mg 5x10mg
EUR 1560

Olaparib (AZD2281)
MBS384995-100mg 100mg
EUR 180

Olaparib (AZD2281)
MBS384995-10mg 10mg
EUR 130

Olaparib (AZD2281)
MBS384995-1mLinDMSO 1mL(inDMSO)
EUR 165

Olaparib (AZD2281)
MBS384995-25mg 25mg
EUR 145

Olaparib (AZD2281)
MBS384995-50mg 50mg
EUR 160

Olaparib-d4-1
HY-10162S3 1 mg
EUR 1709.98
Description: Olaparib-d4-1 is the deuterium labeled Olaparib. Olaparib (AZD2281; KU0059436) is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator[1][2][3][4].

Olaparib (AZD-2281)
200422 200.0mg
EUR 90

Olaparib (AZD2281, KU0059436)
MBS131038-100mg 100mg
EUR 1065

Olaparib (AZD2281, KU0059436)
MBS131038-500mg 500mg
EUR 2775

Olaparib [CAS# 763113-22-0]
O-9201 250 mg
EUR 75

Olaparib (AZD2281, Ku-0059436)
A4154-10 10 mg
EUR 40
Description: Potent PARP1/PARP2 inhibitor

Olaparib (AZD2281, Ku-0059436)
A4154-100 100 mg
EUR 128
Description: Potent PARP1/PARP2 inhibitor

Olaparib (AZD2281, Ku-0059436)
A4154-5.1 10 mM (in 1mL DMSO)
EUR 44
Description: Potent PARP1/PARP2 inhibitor

Olaparib (AZD2281, Ku-0059436)
A4154-500 500 mg
EUR 384
Description: Potent PARP1/PARP2 inhibitor

Olaparib (AZD2281, Ku-0059436)
A4154-S Evaluation Sample
EUR 22
Description: Potent PARP1/PARP2 inhibitor

Olaparib (AZD2281, Ku-0059436)
MBS575811-100mg 100mg
EUR 175

Olaparib (AZD2281, Ku-0059436)
MBS575811-10mg 10mg
EUR 145

Olaparib (AZD2281, Ku-0059436)
MBS575811-200mg 200mg
EUR 195

Olaparib (AZD2281, Ku-0059436)
MBS575811-50mg 50mg
EUR 160

Olaparib (AZD2281, Ku-0059436)
MBS575811-5mg 5mg
EUR 135

N-Descyclopropanecarbaldehyde Olaparib
T36571-10mg 10mg Ask for price
Description: N-Descyclopropanecarbaldehyde Olaparib

N-Descyclopropanecarbaldehyde Olaparib
T36571-1g 1g Ask for price
Description: N-Descyclopropanecarbaldehyde Olaparib

N-Descyclopropanecarbaldehyde Olaparib
T36571-1mg 1mg Ask for price
Description: N-Descyclopropanecarbaldehyde Olaparib

N-Descyclopropanecarbaldehyde Olaparib
T36571-50mg 50mg Ask for price
Description: N-Descyclopropanecarbaldehyde Olaparib

N-Descyclopropanecarbaldehyde Olaparib
T36571-5mg 5mg Ask for price
Description: N-Descyclopropanecarbaldehyde Olaparib

N-Descyclopropanecarbaldehyde Olaparib
MBS5797679-INQUIRE INQUIRE Ask for price

N-Descyclopropanecarbaldehyde Olaparib
HY-75706 10mM/1mL
EUR 54.11
Description: N-Descyclopropanecarbaldehyde Olaparib is an analogue of Olaparib containing DOTA moiety. N-Descyclopropanecarbaldehyde Olaparib is a CRBN-based ligand for synthesizing novel dual EGFR and PARP PROTAC, DP-C-4[1]. N-Descyclopropanecarbaldehyde Olaparib can be radiolabeled F-18 or fluorophore for positron emission tomography (PET) or optical imaging in several types of tumor[2].

Olaptesed pegol
HY-160041 Get quote Ask for price
Description: Olaptesed pegol (NOX-A12) L-oligoribonucleotide aptamer targeting CXCL12 based on a pegylated structure. Olaptesed pegol neutralizes CXCL12, and CXCL12 inhibition mobilizes chronic lymphocytic leukemia cells into the circulation and prevents their homing into the protective microenvironment[1].

Olaptesed pegol (sodium)
HY-160041A Get quote Ask for price
Description: Olaptesed pegol sodium A pegylated-based L-oligoribonucleotide aptamer targeting CXCL12. Olaptesed pegol sodium neutralizes CXCL12, and CXCL12 inhibition mobilizes chronic lymphocytic leukemia cells into the circulation and prevents their homing into the protective microenvironment[1].

OLA1, 1-396aa, Human, His tag, E Coli
MBS204751-002mg 0.02mg
EUR 230

OLA1, 1-396aa, Human, His tag, E Coli
MBS204751-01mg 0.1mg
EUR 405

OLA1, 1-396aa, Human, His tag, E Coli
MBS204751-05mg 0.5mg
EUR 985

OLA1, 1-396aa, Human, His tag, E Coli
MBS204751-5x05mg 5x0.5mg
EUR 4180

Ola1 (untagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug)
RN212538 10 µg Ask for price

Lenti ORF particles, Ola1 (GFP-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), 200ul, >10^7 TU/mL
RR212538L4V 200 µl Ask for price

Lenti ORF particles, Ola1 (Myc-DDK-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), 200ul, >10^7 TU/mL
RR212538L3V 200 µl Ask for price

GTPBP9 (OLA1) (NM_013341) Human Over-expression Lysate
LS029789 100ug
EUR 628
Description: Transient overexpression lysate of Obg-like ATPase 1 (OLA1), transcript variant 1

Ola1 (Myc-DDK-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug)
RR212538 10 µg Ask for price

Lenti ORF clone of Ola1 (mGFP-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug)
RR212538L4 10 µg Ask for price

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9)
MBS6004301-02mL 0.2(mL
EUR 695

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9)
MBS6004301-5x02mL 5x0.2mL
EUR 2975

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (AP)
MBS6327678-02mL 0.2mL
EUR 980

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (AP)
MBS6327678-5x02mL 5x0.2mL
EUR 4250

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (PE)
MBS6327688-02mL 0.2mL
EUR 980

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (PE)
MBS6327688-5x02mL 5x0.2mL
EUR 4250

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (APC)
MBS6327679-02mL 0.2mL
EUR 980

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (APC)
MBS6327679-5x02mL 5x0.2mL
EUR 4250

Lenti ORF clone of Ola1 (Myc-DDK-tagged ORF) - Rat Obg-like ATPase 1 (Ola1), (10 ug)
RR212538L3 10 µg Ask for price

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (FITC)
MBS6327681-02mL 0.2mL
EUR 980

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (FITC)
MBS6327681-5x02mL 5x0.2mL
EUR 4250

OLA1
CSB-CL016318HU1 10 μg plasmid + 200μl Glycerol Ask for price

OLA1
CSB-CL016318HU2 10 μg plasmid + 200μl Glycerol Ask for price

OLA1
enz-637 5µg
EUR 60
Description: Recombinant Human Obg-Like ATPase 1

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (Biotin)
MBS6327680-02mL 0.2mL
EUR 980

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (Biotin)
MBS6327680-5x02mL 5x0.2mL
EUR 4250

OLA1 (untagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 2
SC323754 10 µg Ask for price

OLA1 (untagged)-Human Obg-like ATPase 1 (OLA1), transcript variant 1
SC115293 10 µg Ask for price

OLA1 (GFP-tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 1
RG220834 10 µg Ask for price

OLA1 (GFP-tagged) - Human Obg-like ATPase 1 (OLA1), transcript variant 2
RG202094 10 µg Ask for price

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (Azide free) (HRP)
MBS6327682-02mL 0.2mL
EUR 980

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (Azide free) (HRP)
MBS6327682-5x02mL 5x0.2mL
EUR 4250

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (MaxLight 405)
MBS6327683-01mL 0.1mL
EUR 980

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (MaxLight 405)
MBS6327683-5x01mL 5x0.1mL
EUR 4250

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (MaxLight 490)
MBS6327684-01mL 0.1mL
EUR 980

OLA1, NT (OLA1, GTPBP9, Obg-like ATPase 1, GTP-binding protein 9) (MaxLight 490)
MBS6327684-5x01mL 5x0.1mL
EUR 4250

 

Preconditioning Impression of Extreme-Depth Interval Teaching (HIIT) and Berberine Supplementation on the Gene Expression of Angiogenesis Regulators and Caspase-Three Protein inside the Rats with Myocardial Ischemia-Reperfusion (IR) Hurt

 

Objective: It has been confirmed that angiogenesis is a captivating remedy for victims with ischemic coronary coronary heart sickness. We received right down to study the have an effect on of high-intensity interval teaching (HIIT) and berberine supplementation on the gene expression of angiogenesis-related elements and caspase-Three protein in rats affected by myocardial ischemic-reperfusion hurt.

 

Methods: Fifty rats have been divided into the following groups: (1) expert, (2) berberine supplemented, (3) blended, and (4) IR. Each cohort underwent 5 durations of HIIT per week for a interval of Eight weeks adopted by induction of ischemia. Seven days after completion of reperfusion, modifications inside the gene expression of angiogenesis-related elements and caspase-Three protein have been evaluated inside the coronary coronary heart tissue.

 

Outcomes: We observed a significant distinction between Four groups inside the transcript ranges of vascular endothelial cell improvement subject (VEGF), fibroblast improvement factor-2 (FGF2), and thrombospondin-1(TSP-1) (p ≤ 0.05). Nonetheless, the excellence in endostatin (ENDO) ranges was not very important among the many many groups no matter a discernible low cost (p ≥ 0.05). Moreover, caspase-Three protein and infarct dimension have been significantly lowered inside the intervention groups (p ≤ 0.05), and cardiac carry out elevated in response to these interventions.

 

Conclusion: The therapies exert their impression, likely, by lowering caspase-Three protein and rising the expression of angiogenesis-promoting elements, concomitant with a reduction in inhibitors of the strategy.

 

Explicit miRNA and Gene Deregulation Characterize the Elevated Angiogenic Remodeling of Thoracic Aneurysmatic Aortopathy in Marfan Syndrome

 

Marfan syndrome (MFS) is a connective tissue sickness introduced on by mutations inside the FBN1 gene, leading to alterations inside the extracellular matrix microfibril assembly and the early formation of thoracic aorta aneurysms (TAAs). Non-genetic TAAs share many clinico-pathological parts with MFS and deregulation of some microRNAs (miRNAs) has been demonstrated to be involved inside the improvement of TAA. On this analysis, 40 victims current course of elective ascending aorta surgical process have been enrolled to match TAA histomorphological choices, miRNA profile and related purpose genes with the intention to find specific alterations that can make clear the earlier and further excessive scientific outcomes in MFS victims.

 

Histomorphological, ultrastructural and in vitro analysis have been carried out with the intention to guage aortic wall choices of MFS and non-MFS TAA. MFS displayed higher glycosaminoglycan accumulation and loss/fragmentation of elastic fibers compared with non-MFS TAA. Immunohistochemistry revealed elevated CD133+ angiogenic remodeling, higher MMP-2 expression, irritation and {{smooth}} muscle cell (SMC) turnover in MFS TAA.

 

Cultured SMCs from MFS confirmed elevated turnover and α-smooth muscle actin expression in distinction with non-MFS TAA. Moreover, twenty-five miRNAs, along with miR-26a, miR-29, miR-143 and miR-145, have been found to be downregulated and solely miR-632 was upregulated in MFS TAA in vivo.

 

Bioinformatics analysis revealed that some deregulated miRNAs in MFS TAA are implicated in cell proliferation, extracellular matrix development/carry out and TGFβ signaling. Lastly, gene analysis confirmed 28 upregulated and seven downregulated genes in MFS TAA, a number of of them belonging to the CDH1/APC and CCNA2/TP53 signaling pathways. Explicit miRNA and gene deregulation characterised the aortopathy of MFS and this was associated to elevated angiogenic remodeling, likely favoring the early and further excessive scientific outcomes, compared with non-MFS TAA.

 

Our findings current new insights regarding the pathogenetic mechanisms of MFS TAA; extra investigation is required to substantiate if these newly acknowledged specific deregulated miRNAs might symbolize potential therapeutic targets to counteract the speedy improvement of MFS aortopathy.

Screening for structural variants of 4 candidate genes in canine with problems of intercourse improvement revealed the primary case of a big deletion in NR5A1

 

Problems of intercourse improvement (DSD) are vital causes of infertility and sterility, and are threat components for gonadal carcinogenesis. Many DSDs are brought on by genetic components, primarily intercourse chromosome abnormalities or mutations of genes concerned in sexual improvement, in addition to structural variants (SVs) – massive deletions, duplications, and insertions, if these overlap genes concerned in intercourse improvement.
The purpose of this examine was to find out if there have been SVs in 4 candidate genes – NR0B1 (DAX1), NR5A1, RSPO1, and SOX3 – utilizing droplet digital PCR (ddPCR). There was examine of two cohorts of canine with DSD, together with 55 animals with XX DSD and 15 with XY DSD.
As well as, 40 management females and 10 management males have been included within the examine. Amongst instances, for which there have been evaluations, a big deletion consisting of 4 exons of the NR5A1 gene was recognized in a Yorkshire Terrier with a rudimentary penis, hypospadias, bilateral cryptorchidism, and spermatogenesis inactive testes. That is the primary mutation within the NR5A1 gene resulting in XY DSD phenotype to be reported in home animals.
There have been no SVs within the genes evaluated within the current examine within the cohort of canine with XX DSD. The outcomes from this examine present proof that the big structural variants of those genes are not often related to the DSD phenotype in canine.

Glycitin
T2820-10mg 10mg Ask for price
Description: Glycitin

Glycitin
T2820-1g 1g Ask for price
Description: Glycitin

Glycitin
T2820-1mg 1mg Ask for price
Description: Glycitin

Glycitin
T2820-50mg 50mg Ask for price
Description: Glycitin

Glycitin
T2820-5mg 5mg Ask for price
Description: Glycitin

Glycitin
TB0005 25mg
EUR 223.2

Glycitin
MBS386994-25mg 25mg
EUR 175

Glycitin
MBS386994-50mg 50mg
EUR 210

Glycitin
MBS386994-5x50mg 5x50mg
EUR 930

Glycitin
MBS3608517-100mg 100mg
EUR 325

Glycitin
MBS3608517-10mg 10mg
EUR 215

Glycitin
MBS3608517-25mg 25mg
EUR 240

Glycitin
MBS3608517-50mg 50mg
EUR 260

Glycitin
MBS3608517-5mg 5mg
EUR 200

Glycitin
MBS575279-100mg 100mg
EUR 255

Glycitin
MBS575279-10mg 10mg
EUR 150

Glycitin
MBS575279-25mg 25mg
EUR 180

Glycitin
MBS575279-50mg 50mg
EUR 195

Glycitin
MBS575279-5mg 5mg
EUR 145

Glycitin, >99%
BC036-005 5mg
EUR 230.4

Glycitin, >99%
BC036-010 10mg
EUR 295.2

Glycitin, >99%
BC036-025 25mg
EUR 360

Glycitin 6''-O-Malonate
G635425 100mg
EUR 21000
Description: 137705-39-6

Glycitin (Glycitein 7-O-Glucoside, Glycitein-7-b-O-Glucopyranoside, 7-(b-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4- one)
MBS655485-5mg 5mg
EUR 280

Glycitin (Glycitein 7-O-Glucoside, Glycitein-7-b-O-Glucopyranoside, 7-(b-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4- one)
MBS655485-5x5mg 5x5mg
EUR 1100

Glycitein
540183 10.0mg
EUR 190

Glycitein, >99%
BC035-005 5mg
EUR 278.4

Glycitein, >99%
BC035-010 10mg
EUR 375.6

Glycitein, >99%
BC035-025 25mg
EUR 489.6

Glycitein
GL7698 10mg
EUR 243.55

Glycitein
G635400 10mg
EUR 58
Description: 40957-83-3

Glycitein
HY-N0016 10mg
EUR 357.6

Glycitein
GL7698-10 10
EUR 152.2

Glycitein
GL7698-25 25
EUR 248.6

Glycitein
N1785-20 20 mg
EUR 160
Description: Flavonoid isoflavone

Glycitein
TB0372-0020 20mg
EUR 248.4

Glycitein
T6S0325-10mg 10mg Ask for price
Description: Glycitein

Glycitein
T6S0325-1g 1g Ask for price
Description: Glycitein

Glycitein
T6S0325-1mg 1mg Ask for price
Description: Glycitein

Glycitein
T6S0325-50mg 50mg Ask for price
Description: Glycitein

Glycitein
T6S0325-5mg 5mg Ask for price
Description: Glycitein

Glycitein
MBS385452-25mg 25mg
EUR 240

Glycitein
MBS385452-50mg 50mg
EUR 345

Glycitein
MBS385452-5x50mg 5x50mg
EUR 1550

Glycitein
MBS3608521-10mg 10mg
EUR 315

Glycitein
MBS3608521-5mg 5mg
EUR 255

Glycitein
MBS3608521-5x10mg 5x10mg
EUR 1095

Glycitein
MBS5750969-10mg 10mg
EUR 255

Glycitein
MBS5750969-1mg 1mg
EUR 150

Glycitein
MBS5750969-25mg 25mg
EUR 350

Glycitein
MBS5750969-2mg 2mg
EUR 165

Glycitein
MBS5750969-5mg 5mg
EUR 195

Glycitein-7-O-methyl Ether
G214700 1g
EUR 1200
Description: 75199-40-5

6''-O-xylosyl-glycitin
TBW00285 5mg
EUR 1040.4

6''-O-xylosyl-glycitin
TN3194-10mg 10mg Ask for price
Description: 6''-O-xylosyl-glycitin

6''-O-xylosyl-glycitin
TN3194-1g 1g Ask for price
Description: 6''-O-xylosyl-glycitin

6''-O-xylosyl-glycitin
TN3194-1mg 1mg Ask for price
Description: 6''-O-xylosyl-glycitin

6''-O-xylosyl-glycitin
TN3194-50mg 50mg Ask for price
Description: 6''-O-xylosyl-glycitin

6''-O-xylosyl-glycitin
TN3194-5mg 5mg Ask for price
Description: 6''-O-xylosyl-glycitin

6''-O-xylosyl-glycitin
MBS5786985-10mg 10(mg
EUR 635

6''-O-xylosyl-glycitin
MBS5786985-1mg 1(mg
EUR 260

6''-O-xylosyl-glycitin
MBS5786985-5mg 5(mg
EUR 450

Glycitein (7-Hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one, Glicetein, 7,4'-Dihydroxy-6-methoxyisoflavone)
MBS655489-5mg 5mg
EUR 285

Glycitein (7-Hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one, Glicetein, 7,4'-Dihydroxy-6-methoxyisoflavone)
MBS655489-5x5mg 5x5mg
EUR 1130

Human Glycine(Glycine)ELISA Kit
YLA3881HU-48T 48T Ask for price

Human Glycine(Glycine)ELISA Kit
YLA3881HU-96T 96T Ask for price

Recombinant Glycine max Glycinin
MBS1158931-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1195

Recombinant Glycine max Glycinin
MBS1158931-002mgEColi 0.02mg(E-Coli)
EUR 850

Recombinant Glycine max Glycinin
MBS1158931-002mgYeast 0.02mg(Yeast)
EUR 990

Recombinant Glycine max Glycinin
MBS1158931-01mgEColi 0.1mg(E-Coli)
EUR 1020

Recombinant Glycine max Glycinin
MBS1158931-01mgYeast 0.1mg(Yeast)
EUR 1125

Recombinant Glycine max Glycinin G2 (Gy2)
MBS1206853-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1160

Recombinant Glycine max Glycinin G2 (Gy2)
MBS1206853-002mgEColi 0.02mg(E-Coli)
EUR 795

Recombinant Glycine max Glycinin G2 (Gy2)
MBS1206853-002mgYeast 0.02mg(Yeast)
EUR 945

Recombinant Glycine max Glycinin G2 (Gy2)
MBS1206853-01mgEColi 0.1mg(E-Coli)
EUR 955

Recombinant Glycine max Glycinin G2 (Gy2)
MBS1206853-01mgYeast 0.1mg(Yeast)
EUR 1110

Recombinant Glycine max Glycinin G1 (GY1)
MBS1204835-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1095

Recombinant Glycine max Glycinin G1 (GY1)
MBS1204835-002mgEColi 0.02mg(E-Coli)
EUR 690

Recombinant Glycine max Glycinin G1 (GY1)
MBS1204835-002mgYeast 0.02mg(Yeast)
EUR 845

Recombinant Glycine max Glycinin G1 (GY1)
MBS1204835-01mgEColi 0.1mg(E-Coli)
EUR 805

Recombinant Glycine max Glycinin G1 (GY1)
MBS1204835-01mgYeast 0.1mg(Yeast)
EUR 995

Recombinant Glycine max Glycinin G4 (GY4)
MBS1217846-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1020

Recombinant Glycine max Glycinin G4 (GY4)
MBS1217846-002mgEColi 0.02mg(E-Coli)
EUR 590

Recombinant Glycine max Glycinin G4 (GY4)
MBS1217846-002mgYeast 0.02mg(Yeast)
EUR 775

Recombinant Glycine max Glycinin G4 (GY4)
MBS1217846-01mgEColi 0.1mg(E-Coli)
EUR 705

Recombinant Glycine max Glycinin G4 (GY4)
MBS1217846-01mgYeast 0.1mg(Yeast)
EUR 905

Recombinant Glycine max Glycinin G3 (GY3)
MBS1243346-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1155

Recombinant Glycine max Glycinin G3 (GY3)
MBS1243346-002mgEColi 0.02mg(E-Coli)
EUR 795

Recombinant Glycine max Glycinin G3 (GY3)
MBS1243346-002mgYeast 0.02mg(Yeast)
EUR 945

Recombinant Glycine max Glycinin G3 (GY3)
MBS1243346-01mgEColi 0.1mg(E-Coli)
EUR 950

Recombinant Glycine max Glycinin G3 (GY3)
MBS1243346-01mgYeast 0.1mg(Yeast)
EUR 1105

a-Naphthyl Glycidyl Ether (1-Naphthol Glycidyl Ether, 2-[(1-Naphthyloxy)methyl]oxirane, Naphthyl Glycidyl Ether)
MBS6107755-25g 2.5(g
EUR 525

a-Naphthyl Glycidyl Ether (1-Naphthol Glycidyl Ether, 2-[(1-Naphthyloxy)methyl]oxirane, Naphthyl Glycidyl Ether)
MBS6107755-5x25g 5x2.5g
EUR 2210

Glycine Receptor Subunit alpha 1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, GLRA1)
MBS605777-01mg 0.1mg
EUR 660

Glycine Receptor Subunit alpha 1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, GLRA1)
MBS605777-5x01mg 5x0.1mg
EUR 2820

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (AP)
MBS6131480-01mL 0.1(mL
EUR 875

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (AP)
MBS6131480-5x01mL 5x0.1mL
EUR 3800

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (AP)
MBS6379868-01mL 0.1mL
EUR 920

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (AP)
MBS6379868-5x01mL 5x0.1mL
EUR 3990

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (PE)
MBS6379878-01mL 0.1mL
EUR 920

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (PE)
MBS6379878-5x01mL 5x0.1mL
EUR 3990

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (PE)
MBS6157995-01mL 0.1(mL
EUR 875

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (PE)
MBS6157995-5x01mL 5x0.1mL
EUR 3800

Glycidamide (Oxiranecarboxamide, Glycidic Acid Amide)
MBS6060764-50mg 50(mg
EUR 555

Glycidamide (Oxiranecarboxamide, Glycidic Acid Amide)
MBS6060764-5x50mg 5x50mg
EUR 2340

Gly | glycine
AS09-593 1 mg
EUR 479

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (Biotin)
MBS6142086-01mL 0.1(mL
EUR 875

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (Biotin)
MBS6142086-5x01mL 5x0.1mL
EUR 3800

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) APC
MBS6136783-01mL 0.1(mL
EUR 875

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) APC
MBS6136783-5x01mL 5x0.1mL
EUR 3800

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3) (AP)
MBS6478462-01mL 0.1mL
EUR 1080

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3) (AP)
MBS6478462-5x01mL 5x0.1mL
EUR 4710

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3) (APC)
MBS6478463-01mL 0.1mL
EUR 1080

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3) (APC)
MBS6478463-5x01mL 5x0.1mL
EUR 4710

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3) (FITC)
MBS6478465-01mL 0.1mL
EUR 1080

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3) (FITC)
MBS6478465-5x01mL 5x0.1mL
EUR 4710

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3) (HRP)
MBS6478466-01mL 0.1mL
EUR 1080

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3) (HRP)
MBS6478466-5x01mL 5x0.1mL
EUR 4710

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3) (PE)
MBS6478472-01mL 0.1mL
EUR 1080

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3) (PE)
MBS6478472-5x01mL 5x0.1mL
EUR 4710

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) APC
MBS6379869-01mL 0.1mL
EUR 920

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) APC
MBS6379869-5x01mL 5x0.1mL
EUR 3990

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (Biotin)
MBS6379870-01mL 0.1mL
EUR 920

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (Biotin)
MBS6379870-5x01mL 5x0.1mL
EUR 3990

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (FITC)
MBS6379871-01mL 0.1mL
EUR 920

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (FITC)
MBS6379871-5x01mL 5x0.1mL
EUR 3990

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (HRP)
MBS6379872-01mL 0.1mL
EUR 920

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (HRP)
MBS6379872-5x01mL 5x0.1mL
EUR 3990

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (HRP)
MBS6152692-01mL 0.1(mL
EUR 875

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (HRP)
MBS6152692-5x01mL 5x0.1mL
EUR 3800

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (FITC)
MBS6147389-01mL 0.1(mL
EUR 875

GLRA1 (Glycine Receptor 48kD Subunit, Glycine receptor strychnine-binding subunit, Glycine Receptor Subunit alpha 1) (FITC)
MBS6147389-5x01mL 5x0.1mL
EUR 3800

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3)
MBS621830-01mg 0.1mg
EUR 810

Glycine Receptor alpha 3 subunit (GLRA3, ligand gated ion channel, glycine receptor, alpha-3 polypeptide, glycine receptor, alpha 3)
MBS621830-5x01mg 5x0.1mg
EUR 3495

Glycine
abx082341-500g 500 g
EUR 243.6

Glycine
abx082391-500g 500 g
EUR 226.8

Glycine
20-abx082501
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 kg
  • 500 g
  • 5 kg

Glycine
09591-55 500G
EUR 45.5

Glycine
17109-22 25G
EUR 8.75

Glycine
17109-35 500G
EUR 17.43

Glycine
17109-64 10KG
EUR 127.4

Glycine
17128-14 100G
EUR 19.6

Glycine
17141-24 100G
EUR 14

Glycine
17141-95 500G
EUR 30.8

Glycine
18-107 250g/Unit
EUR 32.97
Description: Molecular/Proteomic Grade

Glycine
18-108 500g/Unit
EUR 59.88
Description: Molecular/Proteomic Grade

Glycine
18-109 1000g/Unit
EUR 103.17
Description: Molecular/Proteomic Grade

Glycine
40700044-1 500 g
EUR 37.33

Glycine
40700044-2 1 kg
EUR 60.54

Glycine
40700044-3 2 kg
EUR 102.65
Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,